{"entity":{"type":"insider","cik":"0001250318","url":"/insider/0001250318","json_url":"/insider/0001250318.json","name":"YACHMETZ PHILIP K","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":43,"n_filings":23,"first":"2004-05-05","last":"2013-10-17","span_basis":"filed_date"},"name_variants":[{"name":"YACHMETZ PHILIP K","source":"filing","n_filings":23,"first_seen":"2004-05-05","last_seen":"2013-10-17"}],"transactions":[{"id":4397201,"accession":"0001181431-13-054179","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001181431-13-054179","line_url":"/filing/0001181431-13-054179#line-7","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (Co-President and CBO)","officer_title":"Co-President and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53411.0,"shares_display":"53,411","price_per_share":0.0982,"price_display":"0.10","price_state":"stated","total_value":5244.9602,"total_display":"5,244.96","shares_owned_after":100545.0,"shares_owned_after_display":"100,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider"},{"id":4397196,"accession":"0001181431-13-054179","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-13-054179","line_url":"/filing/0001181431-13-054179#line-6","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (Co-President and CBO)","officer_title":"Co-President and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.0979,"price_display":"0.10","price_state":"stated","total_value":4895.0,"total_display":"4,895.00","shares_owned_after":153956.0,"shares_owned_after_display":"153,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider"},{"id":4397188,"accession":"0001181431-13-054179","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001181431-13-054179","line_url":"/filing/0001181431-13-054179#line-5","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (Co-President and CBO)","officer_title":"Co-President and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":4000.0,"total_display":"4,000.00","shares_owned_after":203956.0,"shares_owned_after_display":"203,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider"},{"id":4397182,"accession":"0001181431-13-054179","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-13-054179","line_url":"/filing/0001181431-13-054179#line-4","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (Co-President and CBO)","officer_title":"Co-President and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.1015,"price_display":"0.10","price_state":"stated","total_value":2030.0,"total_display":"2,030.00","shares_owned_after":283701.0,"shares_owned_after_display":"283,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider"},{"id":4397178,"accession":"0001181431-13-054179","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-054179","line_url":"/filing/0001181431-13-054179#line-3","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (Co-President and CBO)","officer_title":"Co-President and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":0.0914,"price_display":"0.09","price_state":"stated","total_value":1828.0,"total_display":"1,828.00","shares_owned_after":243956.0,"shares_owned_after_display":"243,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider"},{"id":4397173,"accession":"0001181431-13-054179","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-054179","line_url":"/filing/0001181431-13-054179#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (Co-President and CBO)","officer_title":"Co-President and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19745.0,"shares_display":"19,745","price_per_share":0.0973,"price_display":"0.10","price_state":"stated","total_value":1921.1885,"total_display":"1,921.19","shares_owned_after":263956.0,"shares_owned_after_display":"263,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider"},{"id":4397169,"accession":"0001181431-13-054179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-054179","line_url":"/filing/0001181431-13-054179#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (Co-President and CBO)","officer_title":"Co-President and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":0.0916,"price_display":"0.09","price_state":"stated","total_value":916.0,"total_display":"916.00","shares_owned_after":90545.0,"shares_owned_after_display":"90,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider"},{"id":4589469,"accession":"0001181431-13-007054","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-007054","line_url":"/filing/0001181431-13-007054#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27297.0,"shares_display":"27,297","price_per_share":1.01,"price_display":"1.01","price_state":"stated","total_value":27569.97,"total_display":"27,569.97","shares_owned_after":306904.0,"shares_owned_after_display":"306,904","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-04","filed_date":"2013-02-06","scope":"insider"},{"id":4589467,"accession":"0001181431-13-007054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-007054","line_url":"/filing/0001181431-13-007054#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3203.0,"shares_display":"3,203","price_per_share":1.02,"price_display":"1.02","price_state":"stated","total_value":3267.06,"total_display":"3,267.06","shares_owned_after":303701.0,"shares_owned_after_display":"303,701","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-04","filed_date":"2013-02-06","scope":"insider"},{"id":4731007,"accession":"0001181431-13-003359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-003359","line_url":"/filing/0001181431-13-003359#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1283.0,"shares_display":"1,283","price_per_share":1.14,"price_display":"1.14","price_state":"stated","total_value":1462.62,"total_display":"1,462.62","shares_owned_after":334201.0,"shares_owned_after_display":"334,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-14","filed_date":"2013-01-16","scope":"insider"},{"id":3296860,"accession":"0001181431-12-011053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-011053","line_url":"/filing/0001181431-12-011053#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3540.0,"shares_display":"3,540","price_per_share":2.02,"price_display":"2.02","price_state":"stated","total_value":7150.8,"total_display":"7,150.80","shares_owned_after":235484.0,"shares_owned_after_display":"235,484","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-14","filed_date":"2012-02-23","scope":"insider"},{"id":8965590,"accession":"0001181431-11-049674","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-049674","line_url":"/filing/0001181431-11-049674#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":4.13,"price_display":"4.13","price_state":"stated","total_value":28910.0,"total_display":"28,910.00","shares_owned_after":189024.0,"shares_owned_after_display":"189,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-16","filed_date":"2011-09-16","scope":"insider"},{"id":8975466,"accession":"0001181431-11-010544","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-010544","line_url":"/filing/0001181431-11-010544#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3210.0,"shares_display":"3,210","price_per_share":9.883,"price_display":"9.88","price_state":"stated","total_value":31724.43,"total_display":"31,724.43","shares_owned_after":182024.0,"shares_owned_after_display":"182,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-14","filed_date":"2011-02-15","scope":"insider"},{"id":7643181,"accession":"0001181431-10-009608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-009608","line_url":"/filing/0001181431-10-009608#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3307.0,"shares_display":"3,307","price_per_share":13.7891,"price_display":"13.79","price_state":"stated","total_value":45600.5537,"total_display":"45,600.55","shares_owned_after":167127.0,"shares_owned_after_display":"167,127","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-16","filed_date":"2010-02-17","scope":"insider"},{"id":7643178,"accession":"0001181431-10-009608","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-009608","line_url":"/filing/0001181431-10-009608#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2471.0,"shares_display":"2,471","price_per_share":13.8021,"price_display":"13.80","price_state":"stated","total_value":34104.9891,"total_display":"34,104.99","shares_owned_after":170434.0,"shares_owned_after_display":"170,434","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-02-16","filed_date":"2010-02-17","scope":"insider"},{"id":5895852,"accession":"0001181431-09-055985","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-055985","line_url":"/filing/0001181431-09-055985#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5418.0,"shares_display":"5,418","price_per_share":13.3108,"price_display":"13.31","price_state":"stated","total_value":72117.9144,"total_display":"72,117.91","shares_owned_after":172905.0,"shares_owned_after_display":"172,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-12-09","filed_date":"2009-12-10","scope":"insider"},{"id":5595089,"accession":"0001181431-09-044020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-09-044020","line_url":"/filing/0001181431-09-044020#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":16.25,"price_display":"16.25","price_state":"stated","total_value":60937.5,"total_display":"60,937.50","shares_owned_after":178323.0,"shares_owned_after_display":"178,323","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-15","filed_date":"2009-09-15","scope":"insider"},{"id":5595088,"accession":"0001181431-09-044020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-09-044020","line_url":"/filing/0001181431-09-044020#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3750.0,"shares_display":"3,750","price_per_share":15.75,"price_display":"15.75","price_state":"stated","total_value":59062.5,"total_display":"59,062.50","shares_owned_after":182073.0,"shares_owned_after_display":"182,073","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-14","filed_date":"2009-09-15","scope":"insider"},{"id":9211742,"accession":"0000950117-09-000240","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950117-09-000240","line_url":"/filing/0000950117-09-000240#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP - General Counsel)","officer_title":"SVP - General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5868.0,"shares_display":"5,868","price_per_share":5.7319,"price_display":"5.73","price_state":"stated","total_value":33634.7892,"total_display":"33,634.79","shares_owned_after":185823.0,"shares_owned_after_display":"185,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-17","filed_date":"2009-02-23","scope":"insider"},{"id":5792639,"accession":"0000950117-09-000229","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950117-09-000229","line_url":"/filing/0000950117-09-000229#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP - General Counsel)","officer_title":"SVP - General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5868.0,"shares_display":"5,868","price_per_share":5.7319,"price_display":"5.73","price_state":"stated","total_value":33634.7892,"total_display":"33,634.79","shares_owned_after":185823.0,"shares_owned_after_display":"185,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-02-17","filed_date":"2009-02-19","scope":"insider"},{"id":2863962,"accession":"0000950117-08-001524","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950117-08-001524","line_url":"/filing/0000950117-08-001524#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP - General Counsel)","officer_title":"SVP - General Counsel","security_title":"Common Stock, $0.1 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6400.0,"shares_display":"6,400","price_per_share":4.86,"price_display":"4.86","price_state":"stated","total_value":31104.0,"total_display":"31,104.00","shares_owned_after":166691.0,"shares_owned_after_display":"166,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-09","filed_date":"2008-12-10","scope":"insider"},{"id":3649329,"accession":"0001230295-08-000248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-08-000248","line_url":"/filing/0001230295-08-000248#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (EVP, Chief Business Officer)","officer_title":"EVP, Chief Business Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3785.0,"shares_display":"3,785","price_per_share":19.0011,"price_display":"19.00","price_state":"stated","total_value":71919.1635,"total_display":"71,919.16","shares_owned_after":145811.0,"shares_owned_after_display":"145,811","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-14","filed_date":"2008-04-16","scope":"insider"},{"id":3868249,"accession":"0001230295-08-000139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-08-000139","line_url":"/filing/0001230295-08-000139#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (EVP, Chief Business Officer)","officer_title":"EVP, Chief Business Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2455.0,"shares_display":"2,455","price_per_share":20.0054,"price_display":"20.01","price_state":"stated","total_value":49113.257,"total_display":"49,113.26","shares_owned_after":138271.0,"shares_owned_after_display":"138,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-20","filed_date":"2008-02-20","scope":"insider"},{"id":3868248,"accession":"0001230295-08-000139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-08-000139","line_url":"/filing/0001230295-08-000139#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (EVP, Chief Business Officer)","officer_title":"EVP, Chief Business Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2361.0,"shares_display":"2,361","price_per_share":20.0054,"price_display":"20.01","price_state":"stated","total_value":47232.7494,"total_display":"47,232.75","shares_owned_after":140726.0,"shares_owned_after_display":"140,726","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-02-15","filed_date":"2008-02-20","scope":"insider"},{"id":3824921,"accession":"0001230295-08-000013","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001230295-08-000013","line_url":"/filing/0001230295-08-000013#line-5","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (EVP, Chief Business Officer)","officer_title":"EVP, Chief Business Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":23.1519,"price_display":"23.15","price_state":"stated","total_value":115759.5,"total_display":"115,759.50","shares_owned_after":143087.0,"shares_owned_after_display":"143,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-08","filed_date":"2008-01-09","scope":"insider"},{"id":3824918,"accession":"0001230295-08-000013","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001230295-08-000013","line_url":"/filing/0001230295-08-000013#line-3","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (EVP, Chief Business Officer)","officer_title":"EVP, Chief Business Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":23.0211,"price_display":"23.02","price_state":"stated","total_value":115105.5,"total_display":"115,105.50","shares_owned_after":143087.0,"shares_owned_after_display":"143,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-07","filed_date":"2008-01-09","scope":"insider"},{"id":4056728,"accession":"0001230295-08-000010","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001230295-08-000010","line_url":"/filing/0001230295-08-000010#line-7","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (EVP, Chief Business Officer)","officer_title":"EVP, Chief Business Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":23.2662,"price_display":"23.27","price_state":"stated","total_value":116331.0,"total_display":"116,331.00","shares_owned_after":143087.0,"shares_owned_after_display":"143,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-04","filed_date":"2008-01-04","scope":"insider"},{"id":4056726,"accession":"0001230295-08-000010","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001230295-08-000010","line_url":"/filing/0001230295-08-000010#line-5","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (EVP, Chief Business Officer)","officer_title":"EVP, Chief Business Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.2572,"price_display":"24.26","price_state":"stated","total_value":121286.0,"total_display":"121,286.00","shares_owned_after":143087.0,"shares_owned_after_display":"143,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-03","filed_date":"2008-01-04","scope":"insider"},{"id":4056723,"accession":"0001230295-08-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-08-000010","line_url":"/filing/0001230295-08-000010#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (EVP, Chief Business Officer)","officer_title":"EVP, Chief Business Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":23.4661,"price_display":"23.47","price_state":"stated","total_value":117330.5,"total_display":"117,330.50","shares_owned_after":143087.0,"shares_owned_after_display":"143,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-01-02","filed_date":"2008-01-04","scope":"insider"},{"id":8053136,"accession":"0001230295-07-000753","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-07-000753","line_url":"/filing/0001230295-07-000753#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (EVP, Chief Business Officer)","officer_title":"EVP, Chief Business Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7774.0,"shares_display":"7,774","price_per_share":15.2231,"price_display":"15.22","price_state":"stated","total_value":118344.3794,"total_display":"118,344.38","shares_owned_after":143087.0,"shares_owned_after_display":"143,087","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-10","filed_date":"2007-12-12","scope":"insider"},{"id":8314103,"accession":"0001230295-07-000300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-07-000300","line_url":"/filing/0001230295-07-000300#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (EVP, Chief Business Officer)","officer_title":"EVP, Chief Business Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3805.0,"shares_display":"3,805","price_per_share":12.064,"price_display":"12.06","price_state":"stated","total_value":45903.52,"total_display":"45,903.52","shares_owned_after":150861.0,"shares_owned_after_display":"150,861","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-04-12","filed_date":"2007-04-16","scope":"insider"},{"id":7394187,"accession":"0001230295-07-000158","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-07-000158","line_url":"/filing/0001230295-07-000158#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (EVP, Chief Business Officer)","officer_title":"EVP, Chief Business Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20881.0,"shares_display":"20,881","price_per_share":12.53,"price_display":"12.53","price_state":"stated","total_value":261638.93,"total_display":"261,638.93","shares_owned_after":154666.0,"shares_owned_after_display":"154,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-03-05","filed_date":"2007-03-07","scope":"insider"},{"id":6989723,"accession":"0001230295-07-000137","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-07-000137","line_url":"/filing/0001230295-07-000137#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (EVP, Chief Business Officer)","officer_title":"EVP, Chief Business Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3051.0,"shares_display":"3,051","price_per_share":14.4364,"price_display":"14.44","price_state":"stated","total_value":44045.4564,"total_display":"44,045.46","shares_owned_after":109007.0,"shares_owned_after_display":"109,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-02-15","filed_date":"2007-02-20","scope":"insider"},{"id":5079058,"accession":"0001230295-06-000103","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-06-000103","line_url":"/filing/0001230295-06-000103#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4992.0,"shares_display":"4,992","price_per_share":5.8688,"price_display":"5.87","price_state":"stated","total_value":29297.0496,"total_display":"29,297.05","shares_owned_after":67058.0,"shares_owned_after_display":"67,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-04-12","filed_date":"2006-04-13","scope":"insider"},{"id":1296098,"accession":"0001230295-05-000073","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001230295-05-000073","line_url":"/filing/0001230295-05-000073#line-4","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.22,"price_display":"3.22","price_state":"stated","total_value":9660.0,"total_display":"9,660.00","shares_owned_after":47050.0,"shares_owned_after_display":"47,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-18","filed_date":"2005-05-19","scope":"insider"},{"id":1296097,"accession":"0001230295-05-000073","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001230295-05-000073","line_url":"/filing/0001230295-05-000073#line-3","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":9600.0,"total_display":"9,600.00","shares_owned_after":50050.0,"shares_owned_after_display":"50,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-18","filed_date":"2005-05-19","scope":"insider"},{"id":1296096,"accession":"0001230295-05-000073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001230295-05-000073","line_url":"/filing/0001230295-05-000073#line-2","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.21,"price_display":"3.21","price_state":"stated","total_value":6420.0,"total_display":"6,420.00","shares_owned_after":52050.0,"shares_owned_after_display":"52,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-18","filed_date":"2005-05-19","scope":"insider"},{"id":1296095,"accession":"0001230295-05-000073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001230295-05-000073","line_url":"/filing/0001230295-05-000073#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (SVP, General Counsel)","officer_title":"SVP, General Counsel","security_title":"Common Stock, $.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":3.08,"price_display":"3.08","price_state":"stated","total_value":6160.0,"total_display":"6,160.00","shares_owned_after":44050.0,"shares_owned_after_display":"44,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-05-18","filed_date":"2005-05-19","scope":"insider"},{"id":210763,"accession":"0001125282-04-001957","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001125282-04-001957","line_url":"/filing/0001125282-04-001957#line-5","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (VP, General Counsel)","officer_title":"VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":761.0,"shares_display":"761","price_per_share":19.3,"price_display":"19.30","price_state":"stated","total_value":14687.3,"total_display":"14,687.30","shares_owned_after":7696.0,"shares_owned_after_display":"7,696","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-03","filed_date":"2004-05-05","scope":"insider"},{"id":210762,"accession":"0001125282-04-001957","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001125282-04-001957","line_url":"/filing/0001125282-04-001957#line-4","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (VP, General Counsel)","officer_title":"VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":539.0,"shares_display":"539","price_per_share":19.15,"price_display":"19.15","price_state":"stated","total_value":10321.85,"total_display":"10,321.85","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-03","filed_date":"2004-05-05","scope":"insider"},{"id":210761,"accession":"0001125282-04-001957","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001125282-04-001957","line_url":"/filing/0001125282-04-001957#line-3","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (VP, General Counsel)","officer_title":"VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":19.29,"price_display":"19.29","price_state":"stated","total_value":9645.0,"total_display":"9,645.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-03","filed_date":"2004-05-05","scope":"insider"},{"id":210760,"accession":"0001125282-04-001957","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001125282-04-001957","line_url":"/filing/0001125282-04-001957#line-2","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (VP, General Counsel)","officer_title":"VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":19.28,"price_display":"19.28","price_state":"stated","total_value":1928.0,"total_display":"1,928.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-03","filed_date":"2004-05-05","scope":"insider"},{"id":210759,"accession":"0001125282-04-001957","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001125282-04-001957","line_url":"/filing/0001125282-04-001957#line-1","is_derivative":false,"issuer_cik":"0000835887","issuer_name":"PROGENICS PHARMACEUTICALS INC","issuer_ticker":"PGNX","issuer_name_source":null,"issuer_url":"/issuer/0000835887","owner_cik":"0001250318","owner_name":"YACHMETZ PHILIP K","owner_url":"/insider/0001250318","role":"Officer (VP, General Counsel)","officer_title":"VP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":19.2,"price_display":"19.20","price_state":"stated","total_value":1920.0,"total_display":"1,920.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-05-03","filed_date":"2004-05-05","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":43,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":38,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":43},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000722104","name":"SAVIENT PHARMACEUTICALS INC","url":"/issuer/0000722104","role":"Officer (Co-President and CBO)","n_filings":22,"first_seen":"2005-05-19","last_seen":"2013-10-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000835887","name":"PROGENICS PHARMACEUTICALS INC","url":"/issuer/0000835887","role":"Officer (VP, General Counsel)","n_filings":1,"first_seen":"2004-05-05","last_seen":"2004-05-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001250318","retrieved_at":"2026-08-21T02:02:51+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}